drugset / Trial / NCT00414466
A Safety and Effectiveness Study of Intraspinal Gabapentin (MDT2004) for the Treatment of Chronic Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and minimum effective dose of intraspinal gabapentin when delivered through an implanted drug infusion system.
Timeline
- Start
- 2006-12
- Primary completion
- 2009-12
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gabapentin | Small molecule | 1 mg | Intrathecal |
| Comparator | Gabapentin | Small molecule | 6 mg | Intrathecal |
| Comparator | Gabapentin | Small molecule | 30 mg | Intrathecal |